| Q64073240 | Q64073240 |
| Q47428013 | "Even if I Don't Remember, I Feel Better". A Qualitative Study of Patients with Early-Stage Non-Small Cell Lung Cancer Undergoing Stereotactic Body Radiotherapy or Surgery |
| Q48256303 | A SUVmax-based propensity matched analysis of stereotactic body radiotherapy versus surgery in stage I non-small cell lung cancer: unveiling the role of 18F-FDG PET/CT in clinical decision-making |
| Q37552170 | A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly |
| Q38790915 | A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer |
| Q64964699 | Calculating the individualized fraction regime in stereotactic body radiotherapy for non-small cell lung cancer based on uncomplicated tumor control probability function. |
| Q38685007 | Comparative Analysis of Local Control Prediction Using Different Biophysical Models for Non-Small Cell Lung Cancer Patients Undergoing Stereotactic Body Radiotherapy. |
| Q90136503 | Comparison of Three Radiobiological Models in Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer |
| Q92407282 | Comparison of the Efficacy of Stereotactic Body Radiotherapy versus Surgical Treatment for Early-Stage Non-Small Cell Lung Cancer after Propensity Score Matching |
| Q60908706 | Developments in Stereotactic Body Radiotherapy |
| Q40483664 | Lung cancer treatment is influenced by income, education, age and place of residence in a country with universal health coverage |
| Q36382553 | Monitor unit optimization in stereotactic body radiotherapy for small peripheral non-small cell lung cancer patients |
| Q36550894 | Optimizing the flattening filter free beam selection in RapidArc®-based stereotactic body radiotherapy for Stage I lung cancer |
| Q60938857 | Promising Clinical Outcome With Long Term Follow-Up After Body Gamma Knife Stereotactic Radiosurgery for Patients With Early Stage Non-small Cell Lung Cancer |
| Q36363955 | Radiobiological modeling analysis of the optimal fraction scheme in patients with peripheral non-small cell lung cancer undergoing stereotactic body radiotherapy |
| Q37458027 | Radiobiological modeling of two stereotactic body radiotherapy schedules in patients with stage I peripheral non-small cell lung cancer |
| Q37307675 | Salvage surgery for local failures after stereotactic ablative radiotherapy for early stage non-small cell lung cancer |
| Q42362383 | Stereotactic ablative body radiation therapy or surgery for operable early non-small cell lung cancer patients: bound hand and foot to evidence. |
| Q50096367 | Stereotactic ablative radiotherapy versus lobectomy for stage I non-small cell lung cancer: A systematic review |
| Q38374340 | Stereotactic body radiotherapy in operable patients with stage I NSCLC: where is the evidence? |
| Q39769743 | Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA lung adenocarcinoma: comparison of survival outcomes in two clinical trials with propensity score analysis (JCOG1313-A). |
| Q93064488 | Substantial imbalance that is never eliminated with propensity score matched analyses in comparing surgery to stereotactic body radiotherapy for patients with early-stage non-small cell lung cancer |
| Q90087984 | Surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer: review of meta-analyses |
| Q48369218 | Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review. |
| Q90138365 | Survival of Primary SBRT Compared to Surgery for Operable Stage I/II Non-Small Cell Lung Cancer |
| Q30693104 | Treatment Outcomes in Stage I Lung Cancer: A Comparison of Surgery and Stereotactic Body Radiation Therapy |
| Q42340577 | What is the role of stereotactic ablative radiotherapy in the management of surgically resectable and operable stage I non-small cell lung cancer? |
| Q53373399 | [Radiotherapy in oligometastatic disease]. |